Cargando…

Estrogens still represent an attractive therapeutic approach for Alzheimer’s disease

Detalles Bibliográficos
Autores principales:	Tamagno, Elena, Guglielmotto, Michela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451543/ https://www.ncbi.nlm.nih.gov/pubmed/34100436 http://dx.doi.org/10.4103/1673-5374.314295

Ejemplares similares

Oxidative Stress and Hypoxia Contribute to Alzheimer's Disease Pathogenesis: Two Sides of the Same Coin
por: Guglielmotto, Michela, et al.
Publicado: (2009)

Oxidative Stress Mediates the Pathogenic Effect of Different Alzheimer's Disease Risk Factors
por: Guglielmotto, Michela, et al.
Publicado: (2010)

Oxidative Stress and Beta Amyloid in Alzheimer’s Disease. Which Comes First: The Chicken or the Egg?
por: Tamagno, Elena, et al.
Publicado: (2021)

The Unexpected Role of Aβ(1-42) Monomers in the Pathogenesis of Alzheimer’s Disease
por: Tamagno, Elena, et al.
Publicado: (2018)

The Decrease of Uch-L1 Activity Is a Common Mechanism Responsible for Aβ 42 Accumulation in Alzheimer’s and Vascular Disease
por: Guglielmotto, Michela, et al.
Publicado: (2017)

A silver lining for 24-hydroxycholesterol in Alzheimer's disease: The involvement of the neuroprotective enzyme sirtuin 1
por: Testa, Gabriella, et al.
Publicado: (2018)

While I Still Remember: 30 Years of Alzheimer’s Disease Research
por: Shea, Thomas B.
Publicado: (2018)

Repurposing ibrutinib: therapeutic effects and implications for translational approaches in Alzheimer’s disease
por: Lee, Hyun-ju, et al.
Publicado: (2023)

Is it still worth pursuing the repurposing of metformin as a cancer therapeutic?
por: Lord, Simon R., et al.
Publicado: (2023)

Next generation therapeutics for Alzheimer's disease
por: Bredesen, Dale E, et al.
Publicado: (2013)

Emerging small-molecule therapeutic approaches for Alzheimer's disease and Parkinson's disease based on targeting microRNAs
por: Abdelrahman, Somaya A., et al.
Publicado: (2021)

Voxelotor versus other therapeutic options for sickle cell disease: Are we still lagging behind in treating the disease?
por: Tayyaba Rehan, Syeda, et al.
Publicado: (2022)

Older patients are still under-represented in clinical trials of Alzheimer’s disease
por: Banzi, Rita, et al.
Publicado: (2016)

Untargeted Metabolomics in Forensic Toxicology: A New Approach for the Detection of Fentanyl Intake in Urine Samples
por: Amante, Eleonora, et al.
Publicado: (2021)

New Approaches to Treating Alzheimer’s Disease
por: Zheng, Hailin, et al.
Publicado: (2015)

Active immunotherapy and alternative therapeutic modalities for Alzheimer's disease
por: Weninger, Stacie, et al.
Publicado: (2020)

Cannabinoid pharmacology and its therapeutic uses in Alzheimer’s disease
por: Monteiro, Kadja Luana Chagas, et al.
Publicado: (2020)

TREM2 as an evolving therapeutic target in Alzheimer’s disease
por: George, Jacob
Publicado: (2023)

Diagnostic and therapeutic potential of exosomal miRNAs in Alzheimer’s disease
por: Manna, Ida, et al.
Publicado: (2021)

On the horizon—the value and promise of the global pipeline of Alzheimer's disease therapeutics
por: Cole, Michael A., et al.
Publicado: (2020)

Potential contributions of trace amines in Alzheimer’s disease and therapeutic prospects
por: Dhakal, Sudip, et al.
Publicado: (2020)

Shifting balance from neurodegeneration to regeneration of the brain: a novel therapeutic approach to Alzheimer's disease and related neurodegenerative conditions
por: Iqbal, Khalid, et al.
Publicado: (2014)

Is There Still a Place for Tocilizumab in Coronavirus Disease 2019?
por: Klopfenstein, Timothée, et al.
Publicado: (2021)

Stem Cells and Metastatic Cancer: Fatal Attraction?
por: Fodde, Riccardo
Publicado: (2006)

Evolutionary basins of attraction and convergence in plants and animals
por: Gardiner, John
Publicado: (2013)

Dual targeting nano-approaches for Alzheimer's disease etiology
por: Hettiarachchi, Sajini D., et al.
Publicado: (2020)

Neurovascular ageing: transcriptomic readout and implications on therapeutic targeting in Alzheimer's disease
por: Li, Zhongqi, et al.
Publicado: (2021)

The therapeutic potential of mesenchymal stem cells in Alzheimer's disease: converging mechanisms
por: Turgeman, Gadi
Publicado: (2015)

Using Plants as a Source of Potential Therapeutics for the Treatment of Alzheimer’s Disease
por: Maher, Pamela A.
Publicado: (2020)

CD34(+) progenitor cells as diagnostic and therapeutic targets in Alzheimer’s disease
por: Romaus-Sanjurjo, Daniel, et al.
Publicado: (2022)

Is EAAT2 a potential therapeutic intervention target for Alzheimer’s disease?
por: Wood, Oliver WG, et al.
Publicado: (2023)

Targeting calcium signaling in Alzheimer’s disease: challenges and promising therapeutic avenues
por: Song, LinLin, et al.
Publicado: (2023)

Sleep fragmentation affects glymphatic system through the different expression of AQP4 in wild type and 5xFAD mouse models
por: Vasciaveo, Valeria, et al.
Publicado: (2023)

Understanding axon guidance: attraction, repulsion, and statistical physics
por: Wadsworth, William G.
Publicado: (2015)

Unraveling the Gordian knot: genetics and the troubled road to effective therapeutics for Alzheimer’s disease
por: Restifo, Linda L
Publicado: (2021)

Perspective: Is therapeutic plasma exchange a viable option for treating Alzheimer's disease?
por: Imbimbo, Bruno P., et al.
Publicado: (2020)

Abscisic acid, a promising therapeutic molecule to prevent Alzheimer’s and neurodegenerative diseases
por: Sánchez-Pérez, Ana María
Publicado: (2019)

Vascular dysfunction in Alzheimer’s disease: a biomarker of disease progression and a potential therapeutic target
por: Govindpani, Karan, et al.
Publicado: (2019)

Genes influence facial attractiveness through intricate biological relationships
por: White, Julie D., et al.
Publicado: (2019)

The tumor vasculature an attractive CAR T cell target in solid tumors
por: Akbari, Parvin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8uum3mg748rmk43r3obtrugmim